Suppr超能文献

淋巴结比率作为胰腺癌区域淋巴结受累情况的参数。

Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer.

作者信息

Yamada Suguru, Fujii Tsutomu, Hirakawa Akihiro, Kanda Mitsuro, Sugimoto Hiroyuki, Kodera Yasuhiro

机构信息

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

Biostatistics Section, Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

出版信息

Langenbecks Arch Surg. 2016 Dec;401(8):1143-1152. doi: 10.1007/s00423-016-1412-5. Epub 2016 Apr 5.

Abstract

PURPOSE

To determine which indicators, anatomical nodal metastasis (Japan Pancreas Society, JPS), number of positive lymph nodes (PLN), or lymph node ratio (LNR), is the best means of assessing lymph node involvement in pancreatic cancer.

METHODS

This retrospective study analyzed 275 patients with pancreatic cancer treated at a single institution. Survival curves according to the JPS, PLN, or LNR were assessed by the Kaplan-Meier method. Prognostic value of each classification was explored by Cox regression analysis after adjustments for clinical factors.

RESULTS

Multivariate analysis showed that, relative to n0 in the JPS, hazard ratios (HR) in n1, n2, and n3 were 1.72, 1.73, and 2.75, respectively, with no difference in survival between n1 and n2. Relative to PLN of 0, the HR in the PLN categories of 1∼2, 3, and >3 were 1.39, 1.65, and 3.03, respectively. Relative to LNR of 0, the HR in the categories of 0 < LNR ≤ 0.1, 0.1 < LNR ≤ 0.2, and LNR > 0.2 were 1.27, 2.00, and 5.58, respectively. An incremental increase in the HR was observed as the LNR category progressed, and differences between the survivals were distinct when stratified by the LNR.

CONCLUSIONS

The LNR was an accurate predictor of survival among three assessment strategies and could be proposed as a candidate for use as N categories, pending validation studies.

摘要

目的

确定哪种指标,即解剖学淋巴结转移(日本胰腺协会,JPS)、阳性淋巴结数量(PLN)或淋巴结比率(LNR),是评估胰腺癌淋巴结受累情况的最佳方法。

方法

这项回顾性研究分析了在单一机构接受治疗的275例胰腺癌患者。采用Kaplan-Meier法评估根据JPS、PLN或LNR绘制的生存曲线。在对临床因素进行调整后,通过Cox回归分析探讨每种分类的预后价值。

结果

多变量分析显示,相对于JPS中的n0,n1、n2和n3的风险比(HR)分别为1.72、1.73和2.75,n1和n2之间的生存率无差异。相对于PLN为0,PLN类别为1至2、3和>3时的HR分别为1.39、1.65和3.03。相对于LNR为0,0 < LNR ≤ 0.1、0.1 < LNR ≤ 0.2和LNR > 0.2类别中的HR分别为1.27、2.00和5.58。随着LNR类别进展,观察到HR逐渐增加,按LNR分层时生存差异明显。

结论

在三种评估策略中,LNR是生存的准确预测指标,在验证性研究之前,可作为N分类的候选指标提出。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验